LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 27.89 | 21.74 | 1161 | 1677 | 0.6923 | 0.8861 | MN20160310_N01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 29.86 | 21.74 | 938 | 1887 | 0.4971 | 0.7943 | MN20160310_N01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 29.86 | 21.74 | 980 | 1887 | 0.5193 | 0.8065 | MN20160310_N01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 29.86 | 21.74 | 12 | 1887 | 0.0064 | -0.0881 | MN20160310_N01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 29.86 | 21.74 | 1165 | 1887 | 0.6174 | 0.8557 | MN20160310_N01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 31.83 | 21.74 | 949 | 2110 | 0.4498 | 0.7720 | MN20160310_N01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 31.83 | 21.74 | 975 | 2110 | 0.4621 | 0.7793 | MN20160310_N01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 31.83 | 21.74 | 14 | 2110 | 0.0066 | -0.0645 | MN20160310_N01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 31.83 | 21.74 | 1159 | 2110 | 0.5493 | 0.8265 | MN20160310_N01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 33.80 | 21.74 | 952 | 2381 | 0.3998 | 0.7469 | MN20160310_N01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 33.80 | 21.74 | 978 | 2381 | 0.4107 | 0.7538 | MN20160310_N01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 33.80 | 21.74 | 15 | 2381 | 0.0063 | -0.0533 | MN20160310_N01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 33.80 | 21.74 | 1154 | 2381 | 0.4846 | 0.7972 | MN20160310_N01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 35.77 | 21.74 | 959 | 2602 | 0.3684 | 0.7307 | MN20160310_N01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 35.77 | 21.74 | 983 | 2602 | 0.3777 | 0.7369 | MN20160310_N01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 35.77 | 21.74 | 16 | 2602 | 0.0061 | -0.0434 | MN20160310_N01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 35.77 | 21.74 | 1153 | 2602 | 0.4430 | 0.7775 | MN20160310_N01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 37.74 | 21.74 | 955 | 2828 | 0.3376 | 0.7135 | MN20160310_N01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 37.74 | 21.74 | 977 | 2828 | 0.3454 | 0.7191 | MN20160310_N01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 37.74 | 21.74 | 22 | 2828 | 0.0078 | 0.0017 | MN20160310_N01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 37.74 | 21.74 | 1161 | 2828 | 0.4105 | 0.7619 | MN20160310_N01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 39.71 | 21.74 | 977 | 3084 | 0.3168 | 0.7029 | MN20160310_N01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 39.71 | 21.74 | 1000 | 3084 | 0.3242 | 0.7085 | MN20160310_N01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 39.71 | 21.74 | 24 | 3084 | 0.0078 | 0.0139 | MN20160310_N01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 39.71 | 21.74 | 1186 | 3084 | 0.3846 | 0.7497 | MN20160310_N01 | L22 |